BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ERBB2
,
Angiogenesis
,
Leukemia
,
Pancreas
,
Pharmacogenetics
,
Doxycycline
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Relaxin-2
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Ovarian cancer OVCAR8 cells treated with recombinant protein relaxin-2 (RLN2)
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target.
Production of human pro-relaxin H2 in the yeast Pichia pastoris.
The dual and multifaceted role of relaxin-2 in cancer.
Relaxin family peptides: structure-activity relationship studies.
Human recombinant H2 relaxin induces AKT and GSK3β phosphorylation and HTR-8/SVneo cell proliferatio…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles…
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma
Recombinant Human Relaxin for the Treatment of Decompensated CHF
Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ